What one share of Harvard Apparatus Regenerative Technology holds
We are a clinical-stage biotechnology company focused on the development of regenerative medicine treatments for disorders of the gastro-intestinal system and other organs that result from cancer, trauma or birth defects.
Harvard Apparatus Regenerative Technology’s numbers from its SEC filings, divided by its shares. Results cover the last 12 months to 2026-06-30; the balance sheet is as of 2026-06-30.
| Sales | $0.06 |
|---|---|
| Profit | −$0.39 |
| Cash and investments | $0.02 |
| Book value | −$0.08 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2012 | $0.00 | −$17.35 | $0.80 | −$16.04 | — | — |
| 2013 | $0.06 | −$22.78 | $0.76 | −$20.62 | — | $37.64 |
| 2014 | $0.24 | −$28.29 | $2.98 | −$23.42 | — | $16.53 |
| 2015 | $0.21 | −$20.99 | $0.32 | −$13.20 | — | $11.77 |
| 2016 | $0.10 | −$14.49 | $0.38 | −$11.71 | — | $2.07 |
| 2017 | $0.00 | −$6.63 | $0.08 | −$6.20 | — | $1.37 |
| 2018 | $0.00 | −$1.69 | $0.03 | −$1.74 | — | $0.35 |
| 2019 | $0.00 | −$1.21 | $0.02 | −$0.90 | — | $0.13 |
| 2020 | $0.00 | −$0.55 | $0.00 | −$0.46 | — | $0.12 |
| 2021 | $0.00 | −$0.79 | — | — | — | −$0.28 |
| 2022 | — | −$0.55 | $0.00 | −$0.45 | — | −$0.26 |
| 2023 | $0.01 | −$0.67 | $0.00 | −$0.52 | — | $0.12 |
| 2024 | $0.03 | −$0.52 | $0.00 | −$0.33 | — | $0.20 |
| 2025 | $0.04 | −$0.42 | — | — | — | $0.06 |
Common questions about Harvard Apparatus Regenerative Technology
How much does one share of Harvard Apparatus Regenerative Technology earn?
Over the last 12 months, Harvard Apparatus Regenerative Technology lost $0.39 for each share on $0.06 of sales.
Does Harvard Apparatus Regenerative Technology pay a dividend?
Harvard Apparatus Regenerative Technology didn’t pay a dividend over the last 12 months, according to its SEC filings.
What is Harvard Apparatus Regenerative Technology’s book value per share?
Harvard Apparatus Regenerative Technology’s book value is negative (−$0.08 per share): it owes more than everything it owns is recorded at, often after years of buying back its own shares, as of June 30, 2026.
How much cash and debt does each share of Harvard Apparatus Regenerative Technology have?
Each share of Harvard Apparatus Regenerative Technology has $0.02 of cash and investments, as of June 30, 2026.
Has Harvard Apparatus Regenerative Technology bought back shares?
Harvard Apparatus Regenerative Technology’s share count rose about 4168% from 2012 to 2025. That dilution means each share owns a smaller slice of the company.
From its SEC filings. For education only, not investment advice. New to these words? See the StockSlicer glossary.